WHO Issues Alert Over Acute Shortage of Obesity Injections
Under one in 10 patients eligible to benefit from weight-loss injections such as Wegovy have access to them, caution the global health agency as it issues its inaugural recommendations on the drugs.
Considering in excess of 1,000,000,000 individuals worldwide now living with obesity, it is advocating for more widespread and fairer access to this class of drugs.
According to estimates, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidelines recognises that excess weight is a lifelong illness that can be treated with thorough and lifelong care," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and supply-chain constraints are significant obstacles to broad availability to the jabs that can help people shift substantial weight, notes the organization.
Weight-Loss Drug Shortage
Even under the current most favorable outlook, the production of GLP-1 therapies could only cover approximately 100 million people – under 10% of eligible patients, as stated by the WHO.
The recommendation urges governments and firms to increase access, via strategies including voluntary licensing.
The intellectual property rights on semaglutide – the main component of a leading brand – is set to lapse in several nations in 2026.
How Obesity Jabs Operate
GLP-1 drugs imitate a natural hormone to reduce digestion speed, reduce hunger and boost satiety so individuals eat less.
Individuals usually begin shedding pounds within a few weeks of beginning the regular doses.
Evidence points to people may put most of the weight back on a year later of halting the medication, because their normal hunger resume.
To be overweight or obese increases your chance for experiencing health problems, including type 2 diabetes, cardiovascular issues, stroke, and certain cancers.
Obesity concerns people in all nations and was associated with over three and a half million fatalities worldwide in 2024, per the health agency.
